Tumour gene expression signature in primary melanoma predicts long-term outcomes

Adjuvant systemic therapies are now routinely used following resection of stage III melanoma, however accurate prognostic information is needed to better stratify patients. We use differential expression analyses of primary tumours from 204 RNA-sequenced melanomas within a large adjuvant trial, iden...

Full description

Bibliographic Details
Main Authors:	Garg, M, Couturier, D-L, Nsengimana, J, Fonseca, NA, Wongchenko, M, Yan, Y, Lauss, M, Jönsson, GB, Newton-Bishop, J, Parkinson, C, Middleton, MR, Bishop, T, Sarah, M, Stefanos, N, Tadross, J, Vergara, IA, Lo, S, Felicity, N, Wilmott, JS, Thompson, JF, Long, GV, Scolyer, RA, Corrie, P, Adams, DJ, Brazma, A, Rabbie, R
Format:	Journal article
Language:	English
Published:	Springer Nature 2021

Tumour gene expression signature in primary melanoma predicts long-term outcomes

Similar Items